Gyroscope Therapeutics is based in London, United Kingdom. It has raised $148M in total funding. Latest round: Series C.
Gyroscope Therapeutics is based in London, United Kingdom. Gyroscope Therapeutics has raised $148M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in March 2021. The round record for Gyroscope Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Forbion’s Growth Opportunities Fund, Sofinnova Investments, T. Rowe Price Associates, Inc., Tetragon Financial Group Limited, Fosun Pharma, Cambridge Innovation Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Round data for Gyroscope Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in London and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026